CeriBell, Inc. (CBLL)
Healthcare • Medical Devices
StockNasdaqGSUnited StatesUS15678C1027
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by CeriBell, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:27. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 23 Feb 2027 16:00 | -0.49 | — | — | Upcoming |
| 03 Nov 2026 16:00 | -0.52 | -0.49 | +5.6% | Beat |
| 10 Aug 2026 16:00 | -0.46 | -0.40 | +11.9% | Beat |
| 11 May 2026 16:00 | -0.39 | -0.38 | +3.6% | Beat |
| 24 Feb 2026 16:00 | -0.41 | -0.36 | +12.7% | Beat |
| 04 Nov 2025 16:00 | -0.41 | -0.37 | +10.6% | Beat |
| 05 Aug 2025 16:00 | -0.40 | -0.38 | +4.6% | Beat |
| 08 May 2025 16:00 | -0.46 | -0.36 | +21.2% | Beat |
| 25 Feb 2025 16:00 | -0.31 | -0.40 | -27.5% | Miss |
| 12 Nov 2024 16:00 | -0.87 | -1.85 | -113.2% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 89.1M | +36.1% | -53.4M | -60.0% | -1.46 | +56.9% | -41.6M |
| 2024 | 65.4M | +44.7% | -40.5M | -61.8% | -3.39 | -168.4% | -36.4M |
| 2023 | 45.2M | +74.5% | -29.5M | -65.1% | -1.26 | +20.7% | -30.1M |
| 2022 | 25.9M | — | -37.2M | -143.4% | -1.59 | — | -32.5M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 26.96 | 28.89 | 21.86 | 25.93 | -2.45% | 5,697,765 | |
| Oct 2026 | 24.38 | 28.19 | 22.62 | 26.58 | +8.98% | 11,191,300 | |
| Sep 2026 | 23.82 | 25.63 | 23.04 | 24.39 | +1.71% | 7,496,800 | |
| Aug 2026 | 18.00 | 25.33 | 18.00 | 23.98 | +35.56% | 8,919,800 | |
| Jul 2026 | 19.45 | 20.46 | 15.96 | 17.69 | -9.05% | 7,906,400 | |
| Jun 2026 | 18.40 | 20.76 | 16.99 | 19.45 | +5.42% | 7,764,200 | |
| May 2026 | 20.16 | 20.93 | 15.84 | 18.45 | -8.48% | 6,858,800 | |
| Apr 2026 | 18.40 | 21.65 | 17.63 | 20.16 | +9.98% | 5,113,600 | |
| Mar 2026 | 18.14 | 20.16 | 16.84 | 18.33 | -1.82% | 6,690,600 | |
| Feb 2026 | 20.80 | 21.95 | 17.79 | 18.67 | -9.41% | 6,253,600 | |
| 16 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- CeriBell (CBLL) Climbed, What Is Behind The Fresh Attention? (opens in a new tab) Simply Wall St. · 07 Nov 2026 21:11
- Ceribell (CBLL) Stock Gets Fair Value Bump As Analysts Back Rapid EEG Growth (opens in a new tab) Simply Wall St. · 06 Nov 2026 08:14
- How Raised Revenue Guidance At CeriBell (CBLL) Has Changed Its Investment Story (opens in a new tab) Simply Wall St. · 05 Nov 2026 00:24
- Canaccord Genuity Maintains Buy on CeriBell, Raises Price Target to $33 (opens in a new tab) Benzinga · 04 Nov 2026 19:35
- CeriBell (CBLL) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 04 Nov 2026 16:47
- CeriBell, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 04 Nov 2026 13:30
- CeriBell Inc (CBLL) (Q3 2026) Earnings Call Highlights: Record Hospital Additions and 30% ... (opens in a new tab) GuruFocus.com · 04 Nov 2026 05:11
- CeriBell Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 04 Nov 2026 00:14
- CeriBell, Inc. (CBLL) Reports Q3 Loss, Tops Revenue Estimates (opens in a new tab) Zacks · 03 Nov 2026 23:55
- Ceribell (NASDAQ:CBLL) Falls After In-Line Q3 Revenue and Guidance Below Consensus (opens in a new tab) ChartMill · 03 Nov 2026 23:15
- Compared to Estimates, CeriBell, Inc. (CBLL) Q3 Earnings: A Look at Key Metrics (opens in a new tab) Zacks · 03 Nov 2026 23:00
- Ceribell Reports Third Quarter 2026 Financial Results (opens in a new tab) 03 Nov 2026 21:05
- CeriBell, Inc. (CBLL) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 03 Nov 2026 20:25
- CeriBell Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 03 Nov 2026 18:32
- CeriBell Raises FY2026 Sales Guidance from $114.000M-$117.000M to $115.000M-$117.000M vs $115.537M Est (opens in a new tab) Benzinga · 03 Nov 2026 17:11
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 26.35 USD
- Market cap
- 1.0B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Devices
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow CBLL and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.